Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Obstet Gynecol Reprod Biol ; 169(1): 39-44, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23453296

ABSTRACT

OBJECTIVES: Epidemiological and animal studies have shown that maternal obesity predisposes the offspring to obesity and the metabolic syndrome, possibly via late-onset metabolic programming of the fetus. Little is known, however, about the metabolic effect of maternal obesity on the fetus. This study investigated the effect of a maternal high-fat diet (HFD) on fetal growth and glucose metabolism using a diet-induced obesity mouse model. STUDY DESIGN: Female mice (6 weeks old; C57BL/6N) were fed either a normal chow diet (NCD, 10 kcal% fat) or an HFD (60 kcal% fat) for 4 weeks before mating and throughout pregnancy. At 17 days of gestation, gene expression of inflammatory markers and adipokines in fetal subcutaneous adipose tissue was analyzed by quantitative real-time polymerase chain reaction. RESULTS: HFD mice were overweight, glucose intolerant and insulin resistant compared with NCD mice of the same gestational age. Although fetal body weight was not significantly different, fetal plasma glucose and insulin levels were higher in the HFD group than the NCD group. Furthermore, examination of fetal subcutaneous adipose tissue in the HFD group revealed hypertrophy with an increase in the levels of cluster of differentiation-68, chemokine receptor-2 and tumor necrosis factor-α mRNA, but a decrease in the level of glucose transporter-4 mRNA. CONCLUSION: Maternal HFD causes inflammatory changes in the adipose tissue of offspring.


Subject(s)
Diet, High-Fat , Fetus/metabolism , Inflammation/pathology , Insulin Resistance , Subcutaneous Fat/metabolism , Adipose Tissue , Animals , Antigens, CD/biosynthesis , Antigens, Differentiation, Myelomonocytic/biosynthesis , Female , Fetal Development , Glucose Transporter Type 4/biosynthesis , Insulin/blood , Mice , Mice, Inbred C57BL , Obesity , Pregnancy , Prenatal Exposure Delayed Effects/physiopathology , RNA, Messenger/metabolism , Receptors, CCR2/biosynthesis , Subcutaneous Fat/pathology , Tumor Necrosis Factor-alpha/biosynthesis
2.
Diabetologia ; 53(9): 2046-55, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20512310

ABSTRACT

AIMS/HYPOTHESIS: Experimental studies have suggested that apoptosis is involved in diabetic embryopathy through oxidative stress. However, the precise mechanism of diabetic embryopathy is not yet clear. Thioredoxin (TRX) is a small, ubiquitous, multifunctional protein, which has recently been shown to protect cells from oxidative stress and apoptosis. Using transgenic mice that overproduce human TRX-1 (TRX-Tg mice), we examined whether oxidative stress is involved in fetal dysmorphogenesis in diabetic pregnancies. METHODS: Non-diabetic and streptozotocin-induced diabetic (DM) female mice were mated with male TRX-Tg mice. Pregnant mice were killed either at day 10 or day 17 of gestation, and viable fetuses and their placentas were recovered, weighed and assessed for gross and histological morphology, biochemical markers and gene expression. RESULTS: In both wild-type (WT) and transgenic (Tg) groups, fetal and placental weights in the diabetic group were significantly decreased compared with the non-diabetic group. The incidence of malformation was higher in the diabetic group, and was significantly decreased in the TRX-Tg group (DM-WT vs DM-Tg; 28.6% vs 10.4%). Oxidative stress markers such as thiobarbituric acid reactive substances and 8-hydroxy-2'-deoxyguanosine were increased in DM-WT group fetuses but were decreased in fetuses from the DM-Tg group. Furthermore, immunohistochemically assayed apoptosis and cleaved caspase-3 production in embryonic neuroepithelial cells was significantly increased in the DM-WT group, and was significantly decreased in the DM-Tg group. CONCLUSIONS/INTERPRETATION: These results indicate that oxidative stress is involved in diabetic embryopathy, and that the antioxidative protein TRX at least partially prevents diabetic embryopathy via suppression of apoptosis.


Subject(s)
Apoptosis/physiology , Fetal Diseases/metabolism , Fetal Diseases/prevention & control , Pregnancy in Diabetics/metabolism , Pregnancy in Diabetics/prevention & control , Thioredoxins/metabolism , Animals , Apoptosis/genetics , Diabetes Mellitus, Experimental/genetics , Diabetes Mellitus, Experimental/metabolism , Female , Fetal Diseases/genetics , Humans , Immunohistochemistry , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Models, Biological , Neuroepithelial Cells/cytology , Polymerase Chain Reaction , Pregnancy , Pregnancy in Diabetics/genetics , Thiobarbituric Acid Reactive Substances/metabolism , Thioredoxins/genetics
4.
Fetal Diagn Ther ; 22(6): 425-7, 2007.
Article in English | MEDLINE | ID: mdl-17652929

ABSTRACT

The progress of a fetal severe pleural effusion at mid-trimester is extremely poor. We encountered a fetus that developed a severe left pleural effusion at 21 weeks of gestation. The pleural effusion was removed by thoracocentesis at 22 weeks. Cytology revealed abundant lymphocytes, suggesting chylothorax. However, a reaccumulation of pleural effusion with hydrops was subsequently noted, and a thoracoamniotic shunt with double-basket catheters was installed at 23 weeks. The pleural effusion decreased after 24 weeks and completely disappeared at 26 weeks. At 40 weeks of gestation, a female infant was born by vaginal delivery, with no evidence of pleural effusion. We would like to stress that thoracoamniotic shunt with double-basket catheters in the second trimester is effective for pleural effusion with hydrops.


Subject(s)
Chylothorax/therapy , Fetal Diseases/therapy , Fetal Therapies/instrumentation , Fetal Therapies/methods , Adult , Amniotic Fluid/diagnostic imaging , Catheterization/instrumentation , Catheterization/methods , Chylothorax/diagnosis , Female , Fetal Diseases/diagnosis , Humans , Infant, Newborn , Pleural Effusion/diagnosis , Pleural Effusion/therapy , Pregnancy , Prenatal Diagnosis/instrumentation , Prenatal Diagnosis/methods , Ultrasonography
SELECTION OF CITATIONS
SEARCH DETAIL
...